Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Open accessThe DOI matches its Crossref record; 355 of the 355 references it cites were found in a registry or an index.
Abstract
The Wnt/β-catenin signaling pathway plays a crucial role in various physiological processes, encompassing development, tissue homeostasis, and cell proliferation. Under normal physiological conditions, the Wnt/β-catenin signaling pathway is meticulously regulated. However, aberrant activation of this pathway and downstream target genes can occur due to mutations in key components of the Wnt/β-catenin pathway, epigenetic modifications, and crosstalk with other signaling pathways. Consequently, these dysregulations contribute significantly to tumor initiation and progression. Therapies targeting the Wnt/β-catenin signaling transduction have exhibited promising prospects and potential for tumor treatment. An increasing number of medications targeting this pathway are continuously being developed and validated. This comprehensive review aims to summarize the latest advances in our understanding of the role played by the Wnt/β-catenin signaling pathway in carcinogenesis and targeted therapy, providing valuable insights into acknowledging current opportunities and challenges associated with targeting this signaling pathway in cancer research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Wnt/β-catenin pathway is a well-established oncogenic driver in numerous cancers, including ccRCC, where its aberrant activation is linked to tumor initiation and progression [30–32].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–355 of 355
Bao, X., Zhang, H., Wu, W., Cheng, S., Dai, X., Zhu, X., Fu, Q., Tong, Z., Liu, L., Zheng, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001437 · Cited by 94 · cited 1×
“These gene mutations are considered as pivotal gene mutations associated with the microsatellite status in colon cancer [98].”
BackgroundHe, X. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00165-5 · Cited by 93
Danieau, G., Morice, S., Rédiní, F., Verrecchia, F., & Royer, B. B.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153751 · Cited by 93 · cited 1×
“Similarly, OS is characterized by the presence of EMT, which inhibits key components of intercellular junctions, including E-cadherin, thereby promoting the invasiveness of cancer cells [272].”
BackgroundCoactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
Stauffer, J. K., Scarzello, A. J., Andersen, J. B., Kluyver, R. L. D., Back, T. C., Weiss, J. M., Thorgeirsson, S. S., & Wiltrout, R. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2705 · Cited by 93
Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells
Chen, C., Zhao, M., Tian, A., Zhang, X., Yao, Z., & Ma, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4100 · Cited by 92 · cited 1×
“Numerous studies have demonstrated that dysregulated activation of the canonical Wnt signaling pathway contributes to both the development and metastasis of OS [268, 269].”
BackgroundCancer‐associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer
Aizawa, T., Karasawa, H., Funayama, R., Shirota, M., Suzuki, T., Maeda, S., Suzuki, H., Yamamura, A., Naitoh, T., Nakayama, K., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2523 · Cited by 92 · cited 1×
“Additionally, cancer-associated fibroblasts (CAF) can enhance invasion and migration of colorectal cancer cells by releasing Wnt2 protein [213].”
BackgroundRanes, M., Zaleska, M., Sakalas, S., Knight, R., & Guettler, S. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.013 · Cited by 92 · cited 1×
“In the absence of Wnt binding, cytoplasmic β-catenin undergoes phosphorylation by a destruction complex (DC) consisting of adenomatous polyposis coli (APC), Axis inhibition protein (AXIN), glycogen synthase kinase 3β (GSK3β), casein kinase 1α (CK1α), and E3 ubiquitin ligase β-TrCP (SCFβ-TrCP) [26].”
BackgroundLi, N., Lu, N., & Xie, C. (2019) · The FEBS Journal · doi:10.1111/febs.15017 · Cited by 91 · cited 1×
“The core effectors YAP/TAZ in the Hippo signaling pathway have direct interactions with β-catenin in the Wnt signaling pathway to promote gastrointestinal tumor development [179].”
BackgroundShimizu, Y., Ikeda, S., Fujimori, M., Kodama, S., Nakahara, M., Okajima, M., & Asahara, T. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1226 · Cited by 91
miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer
Sun, X., Dongol, S., Qiu, C., Xu, Y., Sun, C., Zhang, Z., Yang, X., Zhang, Q. H., & Kong, B. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0267 · Cited by 90 · cited 1×
“In endometrial cancer, the expression of RORA is downregulated by miR-652 followed by the activation of Wnt/β-catenin signalling [150].”
BackgroundMahmoudvand, S., Shokri, S., Taherkhani, R., & Farshadpour, F. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i1.42 · Cited by 89
Bruun, J., Kolberg, M., Nesland, J. M., Svindland, A., Nesbakken, A., & Lothe, R. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00118 · Cited by 89 · cited 1×
“In a cohort of 720 colorectal cancer patients, the deletion of membrane β-cyclins was predominantly associated with a poor prognosis, as evidenced by overall survival analysis [198].”
BackgroundWnt signaling in castration-resistant prostate cancer: implications for therapy.
Yokoyama, N. N., Shao, S., Hoang, B. H., Mercola, D., & Zi, X. (2014) · PubMed · Cited by 89
PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers
Zhong, Z., Sepramaniam, S., Chew, X. H., Wood, K., Lee, M. A., Madan, B., & Virshup, D. M. (2019) · Oncogene · doi:10.1038/s41388-019-0908-1 · Cited by 87 · cited 1×
“Notably, the combination of ETC-159 (a PORCN inhibitor) and GDC-0941(a PI3K inhibitor) has demonstrated remarkable inhibition of proliferation in RNF43-mutant pancreatic cancer cells and effectively suppressed the growth of xenografts in vivo [288].”
BackgroundDetection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses
Mairal, A., Pinglier, E., Gilbert, E., Peter, M., Validire, P., Desjardins, L., Doz, F., Aurias, A., & Couturier, J. (2000) · Genes, Chromosomes and Cancer · doi:10.1002/1098-2264(200008)28:4<370::aid-gcc2>3.0.co;2-8 · Cited by 85
Unno, K., Chalmers, Z. R., Pamarthy, S., Vatapalli, R. J., Rodríguez, Y., Lysy, B., Mok, H., Sagar, V., Han, H., Yoo, Y. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3351 · Cited by 85
Galamb, O., Kalmár, A., Péterfia, B. F., Csabai, I., Bodor, A., Ribli, D., Krenács, T., Patai, Á. V., Wichmann, B., Barták, B. K., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1190894 · Cited by 84
Björklund, P., Lindberg, D. M., Åkerström, G., & Westin, G. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-53 · Cited by 84 · cited 1×
“In parathyroid adenomas, DNA sequencing demonstrates the presence of stabilizing homozygous mutations in 7.3% of patients while aberrant β-catenin accumulation is commonly observed at a high frequency [101].”
BackgroundInfluentialMinke, K. S., Staib, P., Puetter, A., Gehrke, I., Gandhirajan, R. K., Schlösser, A., Schmitt, E. K., Hallek, M., & Kreuzer, K. (2009) · European Journal of Haematology · doi:10.1111/j.1600-0609.2008.01188.x · Cited by 82
Adenomatous polyposis coli proteins and cell adhesion
Bienz, M., & Hamada, F. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.08.001 · Cited by 81
Evidence for tankyrases as antineoplastic targets in lung cancer
Busch, A. M., Johnson, K. C., Stan, R. V., Sanglikar, A., Ahmed, Y., Dmitrovsky, E., & Freemantle, S. J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-211 · Cited by 81
Mizutani, A., Yashiroda, Y., Muramatsu, Y., Yoshida, H., Chikada, T., Tsumura, T., Okue, M., Shirai, F., Fukami, T., Yoshida, M., et al. (2018) · Cancer Science · doi:10.1111/cas.13805 · Cited by 80
Wnt Signaling in Cancer: Not a Binary ON:OFF Switch
Flanagan, D. J., Vincan, E., & Phesse, T. J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1362 · Cited by 80 · cited 1×
“OMP-18R5, also known as vanticumab, is a mAb targeting human FZD1, 2, 5, 7, and 8 [231, 348].”
BackgroundNotch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Mangolini, M., Götte, F., Moore, A., Ammon, T., Oelsner, M., Lutzny‐Geier, G., Klein‐Hitpaß, L., Williamson, J. C., Lehner, P. J., Dürig, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06069-5 · Cited by 78 · cited 2×
“Besides, stromal Notch2 activity plays a regulatory role in N-cadherin expression within CLL cells, which interacts with and further stabilizes β-catenin [177].”
BackgroundCatrow, J. L., Zhang, Y., Zhang, M., & Ji, H. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00223 · Cited by 78 · cited 1×
“Furthermore, NLS-StAx-h, a selective cell-penetrating peptide inhibitor of β-catenin transcriptional factor interaction, effectively inhibits the proliferation and migration of colorectal cancer cells [329].”
BackgroundLee, M. A., Park, J.-H., Rhyu, S. Y., Oh, S.-T., Kang, W.-K., & Kim, H.-N. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-125 · Cited by 77 · cited 1×
“Furthermore, the Wnt/β-catenin signaling pathway exhibits crosstalk with other pathways and actively participates in the regulation of tumor microenvironment [210, 211].”
BackgroundLZTS2 Is a Novel β-Catenin-Interacting Protein and Regulates the Nuclear Export of β-Catenin
Thyssen, G., Li, T.-H., Lehmann, L., Zhuo, M., Sharma, M., & Sun, Z. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01031-06 · Cited by 76
Targeting molecular pathways in cancer stem cells by natural bioactive compounds
Cianciosi, D., Varela-Lopez, A., Forbes-Hernandez, T. Y., Gasparrini, M., Afrin, S., Reboredo-Rodriguez, P., Zhang, J., Quiles, J. L., Nabavi, S. F., Battino, M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.006 · Cited by 76 · cited 1×
“Additionally, ICG-001 selectively target human CSCs, leading to the disruption of the CBP/β-catenin complex and the formation of a specific Sam68/CBP complex within the CSCs [334].”
BackgroundTargeting Wnt/β‐catenin and PI3K/Akt/mTOR pathways in T‐cell acute lymphoblastic leukemia
Evangelisti, C., Chiarini, F., Cappellini, A., Paganelli, F., Fini, M., Santi, S., Martelli, A. M., Neri, L. M., & Evangelisti, C. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29429 · Cited by 76 · cited 1×
“In recent years, several SMIs targeting CBP, which acts as one of the coactivators for β-catenin-dependent transcription, have emerged and exhibited promising anti-tumor effects in preclinical models [331–333].”
BackgroundWnt proteins synergize to activate β-catenin signaling
Alok, A., Lei, Z., Jagannathan, N. S., Kaur, S., Harmston, N., Rozen, S. G., Tucker-Kellogg, L., & Virshup, D. M. (2017) · Journal of Cell Science · doi:10.1242/jcs.198093 · Cited by 75 · cited 1×
“FZD protein are seven-span transmembrane receptors that are associated with low-density lipoprotein receptor 5 (LRP5) and LRP6, acting as co-receptors for FZD [17, 19, 22, 23].”
BackgroundJin, H., Luo, S., Wang, Y., Liu, C., Piao, Z., Xu, M., Guan, W., Li, Q., Zou, H., Tan, Q.-Y., et al. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.06.008 · Cited by 75 · cited 1×
“For instance, miR-135b has been identified as capable of activating β-catenin expression in osteosarcoma cells and enhancing the Wnt/β-catenin signaling [137].”
BackgroundWnt Signaling in Gynecologic Malignancies
McMellen, A. N., Woodruff, E. R., Corr, B. R., Bitler, B. G., & Moroney, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124272 · Cited by 74 · cited 1×
“Hotspot mutations in Exon 3 of CTNNB1 alter the N-terminus of β-catenin, impeding its phosphorylation and degradation by DC, thereby resulting in β-catenin accumulation [99].”
BackgroundYan, R., Fan, X., Xiao, Z., Liu, H., Huang, X., Liu, J., Zhang, S., Yao, J., An, G., & Ge, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.030 · Cited by 73 · cited 1×
“Stem cells are characterized by their inherent capacity for self-renewal and differentiation [48].”
BackgroundNakamura, T., Nakamura, T., & Matsumoto, K. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00201.x · Cited by 73 · cited 1×
“This three-component complex would contribute to rapid endocytosis and subsequent removal of this protein from the plasma membrane [67, 68].”
BackgroundGDE2-Dependent Activation of Canonical Wnt Signaling in Neurons Regulates Oligodendrocyte Maturation
Choi, B.-R., Cave, C., Na, C. H., & Sockanathan, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107540 · Cited by 72 · cited 1×
“It plays an indispensable role in a wide range of physiological processes encompassing proliferation, differentiation, apoptosis, migration, invasion and tissue homeostasis [1–3].”
BackgroundXiang, Q., Wang, C., Zhang, Y., Xue, X., Song, M., Zhang, C., Li, C., Wu, C., Li, K., Hui, X. H., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.087 · Cited by 71
Belenguer, G., Mastrogiovanni, G., Pacini, C., Hall, Z., Dowbaj, A. M., Arnes-Benito, R., Sljukic, A., Prior, N., Kakava, S., Bradshaw, C. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27923-z · Cited by 71 · cited 1×
“Its mutation is frequently observed in several carcinoma types including HCC, pancreatic adenocarcinoma, and CRC [93–95].”
BackgroundNagaraj, A. B., Knarr, M., Sekhar, S. C., Connor, R. S., Joseph, P. L., Kovalenko, O., Fleming, A., Surti, A., Nurmemmedov, E., Beltrame, L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2041 · Cited by 71
Kruck, S., Eyrich, C., Scharpf, M., Sievert, K.-D., Fend, F., Stenzl, A., & Bedke, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610944 · Cited by 70 · cited 1×
“Some of these aberrations include upregulation of Wnt1 [249] and Wnt10a [250], as well as downregulation of Wnt5a [251] and Wnt7a [252].”
BackgroundAgarwal, P., Zhang, B., Ho, Y., Cook, A., Li, L., Mikhail, F. M., Wang, Y., McLaughlin, M. E., & Bhatia, R. (2017) · Blood · doi:10.1182/blood-2016-05-714089 · Cited by 70 · cited 1×
“Among these inhibitors, Wnt974 (LGK974) particularly noteworthy for its demonstrated efficacy in various tumor models including mouse mammary tumor virus-Wnt-1 (MMTV-Wnt1) mouse model and models of human head and neck squamous cell carcinoma [279, 280].”
BackgroundWNT10A Plays an Oncogenic Role in Renal Cell Carcinoma by Activating WNT/β-catenin Pathway
Hsu, R.-J., Ho, J.-Y., Cha, T.-L., Yu, D.-S., Wu, C.-L., Huang, W.-P., Chu, P., Chen, Y.-H., Chen, J.-T., & Yu, C.-P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047649 · Cited by 70 · cited 1×
“Some of these aberrations include upregulation of Wnt1 [249] and Wnt10a [250], as well as downregulation of Wnt5a [251] and Wnt7a [252].”
BackgroundPaluszczak, J., Sarbak, J., Kostrzewska‐Poczekaj, M., Kiwerska, K., Jarmuż‐Szymczak, M., Grenman, R. A., Mielcarek-Kuchta, D., & Baer‐Dubowska, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-2913-x · Cited by 70
Twa1/Gid8 is a β-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis
Lu, Y., Xie, S., Zhang, W., Zhang, C., Gao, C., Sun, Q., Cai, Y., Xu, Z., Xiao, M., Xu, Y., et al. (2017) · Cell Research · doi:10.1038/cr.2017.107 · Cited by 69 · cited 1×
“This effect is mediated by its conserved CRA (CT11-RanBPM) domain, which interacts with β-catenin [78].”
BackgroundDetection of point mutations of the Axin1 gene in colorectal cancers
Jin, L., Shao, Q., Luo, W., Ye, Z., Li, Q., & Lin, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11435 · Cited by 68
Powell, A. E., Vlacich, G. R., Zhao, Z., McKinley, E. T., Washington, M. K., Manning, H. C., & Coffey, R. J. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00358.2013 · Cited by 68 · cited 1×
“Several characteristics have been identified in stem cells, including Lgr5, Bmi1, Lrig1 and Dclk1 [205–207].”
BackgroundBrune, J. C., Tormin, A., Johansson, M. C., Rissler, P., Brosjö, O., Löfvenberg, R., von Steyern, F. V., Mertens, F., Rydholm, A., & Scheding, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.25697 · Cited by 65 · cited 1×
“Human OS cells possessing MSC characteristics exhibit distinct genetic profiles compared to other tumor cell types, enabling them to maintain an undifferentiated state [267].”
BackgroundThe genetic basis for inactivation of Wnt pathway in human osteosarcoma
Du, X., Yang, J., Yang, D., Tian, W., & Zhu, Z. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-450 · Cited by 62 · cited 1×
“The inactivation of the Wnt/β-catenin pathway, particularly through the deletion of genes associated with this signaling pathway, such as c-myc and cyclin D1 proteins, also contributes to the development of OS [271].”
BackgroundMiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1
Zhang, L., Chen, Y., Jia, J., Zhu, X., He, Y., & Wu, L.-M. (2019) · Cancer Biomarkers · doi:10.3233/cbm-181229 · Cited by 62
Hosein, A. N., Dangol, G., Okumura, T., Roszik, J., Rajapakshe, K., Siemann, M., Zaid, M., Ghosh, B., Monberg, M., Guerrero, P. A., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.273 · Cited by 61
Wessel Stratford, E., Daffinrud, J., Munthe, E., Castro, R., Waaler, J., Krauss, S., & Myklebost, O. (2014) · Cancer Medicine · doi:10.1002/cam4.170 · Cited by 61
Wnt antagonist DICKKOPF‐3 (Dkk‐3) induces apoptosis in human renal cell carcinoma
Ueno, K., Hirata, H., Majid, S., Chen, Y., Zaman, M. S., Tabatabai, Z. L., Hinoda, Y., & Dahiya, R. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20729 · Cited by 61 · cited 1×
“DKK1 is an inhibitor of the Wnt signaling pathway while DKK3 is generally considered to act as a tumor suppressor [259].”
BackgroundA novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors
Menon, M., Elliott, R., Bowers, L., Balan, N., Rafiq, R., Costa-Cabral, S., Munkonge, F., Trinidade, I., Porter, R., Campbell, A. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36447-4 · Cited by 60
Wu, G., Cao, L., Zhu, J., Tan, Z., Tang, M., Li, Z., Hu, Y., Yu, R., Zhang, S., Song, L., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2554 · Cited by 60 · cited 1×
“In cases of chemotherapy-resistant EOC with overactivated CBP/β-catenin signaling pathway, PRI-724 has been found to enhance sensitivity of tumor to platinum chemotherapy while exhibiting significant toxicity in preclinical investigations [336, 337].”
BackgroundLi, J., Xie, G., Tian, Y., Li, W., Wu, Y., Chen, F., Lin, Y., Lin, X., Au, S. W.-N., Cao, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.019 · Cited by 59
Song, J. K., Du, Z., Ravasz, M., Dong, B., Wang, Z., & Ewing, R. M. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0644 · Cited by 59 · cited 1×
“DNMT1 is a key mediator for the proper functioning of β-catenin, which is responsible for the formation of the DNMT1-β-catenin complex to mediate DNMT-depen-dent promoter methylation and targeted gene expression within the Wnt/β-catenin pathway [133].”
BackgroundHedgehog inhibits β-catenin activity in synovial joint development and osteoarthritis
Rockel, J. S., Yu, C., Whetstone, H., Craft, A. M., Reilly, K., Ma, H., Tsushima, H., Puviindran, V., Al-Jazrawe, M., Keller, G. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80205 · Cited by 58 · cited 1×
“In adults, sustained HH signaling activity results in cartilage degeneration, whereas increasing β-catenin activity may counteract this effect by rebalancing HH and Wnt/β-catenin signaling [183].”
BackgroundFischer, M. M., Yeung, V. P., Cattaruzza, F., Hussein, R., Yen, W.-C., Murriel, C., Evans, J. W., O’Young, G., Brunner, A. L., Wang, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15704-y · Cited by 58 · cited 1×
“The RSPO family comprises a group of secreted proteins synthesized by stromal cells within the tumor microenvironment that augment Wnt signaling [214].”
BackgroundSileo, P., Simonin, C., Melnyk, P., Chartier‐Harlin, M., & Cotelle, P. (2022) · Cells · doi:10.3390/cells11223631 · Cited by 57 · cited 1×
“The Hippo pathway consists of a cascade of kinases that govern the phosphorylation of the co-activators of Yes-associated protein (YAP) and a transcriptional coactivator with PDZ-biding motif (TAZ) [178].”
BackgroundBernkopf, D. B., Brückner, M., Hadjihannas, M. V., & Behrens, J. (2019) · Nature Communications · doi:10.1038/s41467-019-12203-8 · Cited by 54
Bilim, V. N., Kawasaki, T., Katagiri, A., Wakatsuki, S., Takahashi, K., & Tomita, Y. (2000) · PubMed · Cited by 54
Tao, J., Krutsenko, Y., Moghe, A., Singh, S., Poddar, M., Bell, A., Oertel, M., Singhi, A. D., Geller, D., Chen, X., et al. (2021) · Hepatology · doi:10.1002/hep.31730 · Cited by 54
Lu, W., Liu, C.-C., Thottassery, J. V., Bu, G., & Li, Y. (2010) · Biochemistry · doi:10.1021/bi1001486 · Cited by 53 · cited 1×
“Furthermore, Mesd demonstrates the ability to inhibit LRP6 phosphorylation and Wnt/β-catenin signaling in prostate cancer PC-3 cells, resulting in the suppression of PC-3 cell proliferation [293].”
BackgroundEto, T., Miyake, K., Nosho, K., Ohmuraya, M., Imamura, Y., Arima, K., Kanno, S., Fu, L., Kiyozumi, Y., Izumi, D., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5098 · Cited by 53 · cited 1×
“Its mutation is frequently observed in several carcinoma types including HCC, pancreatic adenocarcinoma, and CRC [93–95].”
BackgroundUnlocking the Wnt pathway: Therapeutic potential of selective targeting FZD7 in cancer
Larasati, Y. A., Boudou, C., Koval, A., & Katanaev, V. L. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.12.008 · Cited by 53 · cited 2×
“Additionally, computational docking has identified ZINC05972969 as another small molecule that targets FZD7 [290].”
BackgroundCarayol, N., & Wang, C. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.02.014 · Cited by 52
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
Doo, D. W., Meza-Perez, S., Londoño, A. I., Goldsberry, W. N., Katre, A. A., Boone, J. D., Moore, D. J., Hudson, C. T., Betella, I., McCaw, T. R., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920913798 · Cited by 52 · cited 1×
“In vitro studies have also revealed the ability of LGK974 to diminish the viability of epithelial ovarian cancer (EOC) cells and impede tumor growth in vivo [281].”
BackgroundWnt/β-catenin–activated Ewing sarcoma cells promote the angiogenic switch
Hawkins, A. G., Pedersen, E. A., Treichel, S., Temprine, K., Sperring, C. P., Read, J. A., Magnuson, B., Chugh, R. K., & Lawlor, E. R. (2020) · JCI Insight · doi:10.1172/jci.insight.135188 · Cited by 52
Characterization of Tiki, a New Family of Wnt-specific Metalloproteases
Zhang, X., MacDonald, B. T., Gao, H., Shamashkin, M., Coyle, A. J., Martinez, R. V., & He, X. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677807 · Cited by 51 · cited 1×
“Tiki represents a family of Wnt-specific proteases that would directly inhibit Wnt signaling by hydrolyzing the terminal of Wnt3a and triggering the transformation of Wnt3a into oxidized oligomers, thereby depriving its ability to bind receptors [54, 55].”
BackgroundLi, B., Orton, D., Neitzel, L. R., Astudillo, L., Shen, C., Long, J., Chen, X., Kirkbride, K. C., Doundoulakis, T., Guerra, M. L., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aak9916 · Cited by 50 · cited 1×
“SSTC3, a small molecule activator of CK1α, can inhibit the growth of heterologous transplants in CRC [321, 322].”
BackgroundCheng, D., Liu, J., Han, D., Zhang, G., Gao, W., Hsieh, M. H., Ng, N., Kasibhatla, S., Tompkins, C., Li, J., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00038 · Cited by 50 · cited 1×
“Furthermore, GNF-6231 has exhibited significant inhibitory effects on breast cancer in a mouse model [289].”
BackgroundThe complex roles of Wnt antagonists in RCC
Saini, S., Majid, S., & Dahiya, R. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.146 · Cited by 50 · cited 1×
“These aberrations encompass the down-regulation of sFRP members, the DKK family, and WIF1, among others [257].”
BackgroundAlteration of Frizzled Expression in Renal Cell Carcinoma
Janssens, N., Andries, L. J., Janicot, M., Perera, T., & Bakker, A. C. (2004) · Tumor Biology · doi:10.1159/000081098 · Cited by 49 · cited 1×
“In addition, RCC also exhibits elevated mRNA levels of Wnt receptors FZD5 and FZD8, resulting in increased cyclin D1 [253].”
BackgroundZhu, L., Yang, N., Du, G., Li, C., Liu, G., Liu, S., Xu, Y., Di, Y., Pan, W., & Li, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26762 · Cited by 49
Okada-Iwasaki, R., Takahashi, Y., Watanabe, Y., Ishida, H., Saito, J.-I., Nakai, R., & Asai, A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0938 · Cited by 48
Li, S., Han, Z., Zhao, N., Zhu, B., Zhang, Q., Yang, X., Sheng, D., Hou, J., Guo, S., Wei, L., et al. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.014 · Cited by 48
TLE1 Is an Anoikis Regulator and Is Downregulated by Bit1 in Breast Cancer Cells
Brunquell, C., Biliran, H., Jennings, S., Ireland, S. K., Chen, R., & Ruoslahti, E. I. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0144 · Cited by 47 · cited 1×
“The aberrant activation of the Wnt/catenin pathway in breast cancer is predominantly induced by epigenetic alterations in constituent elements, such as C-terminal binding protein [227] and Groucho-related transcriptional repressor protein [228].”
BackgroundJiang, Y., Luo, W., & Howe, P. H. (2009) · Oncogene · doi:10.1038/onc.2009.157 · Cited by 46 · cited 2×
“This process would ultimately result in the accumulation of β-catenin[73].”
BackgroundYanai, H., Atsumi, N., Tanaka, T., Nakamura, N., Komai, Y., Omachi, T., Tanaka, K., Ishigaki, K., Saiga, K., Ohsugi, H., et al. (2017) · Scientific Reports · doi:10.1038/srep41838 · Cited by 45
MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin
Qian, C., Wang, B., Zou, Y., Zhang, Y., Hu, X., Sun, W., Xiao, H., Liu, H., & Shi, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s210076 · Cited by 45
Kim, H., Choi, S., Yoon, J., Lim, H. J., Lee, H., Choi, J., Ro, E. J., Heo, J., Lee, W., No, K. T., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505714 · Cited by 44
Sun, T., Yin, Y., Jin, H., Liu, H., & Tian, W. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12449 · Cited by 44
Shen, C., Nayak, A., Neitzel, L. R., Adams, A. A., Silver-Isenstadt, M., Sawyer, L. M., Benchabane, H., Wang, H., Bunnag, N., Li, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25634-z · Cited by 43 · cited 1×
“CK1α strictly modulates the canonical Wnt signal transduction and serves as a negative regulator of Wnt signaling, playing a crucial role in the formation of DC and subsequent phosphorylation of β-catenin [318].”
BackgroundQuackenbush, K. S., Bagby, S., Tai, W. M., Messersmith, W. A., Schreiber, A., Greene, J., Kim, J., Wang, G., Purkey, A., Pitts, T. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8626 · Cited by 43 · cited 1×
“…which target β-catenin, AXIN, APC, and other components involved in pathway activation; (3) nuclear level inhibitors, which modulate the transcription of transcription of target genes, such as transcriptional co-factors; and (4) inhibitors that interact with other signaling pathways [315].”
BackgroundDifferential effect of NF‐κB activity on β‐catenin/Tcf pathway in various cancer cells
Cho, H. H., Song, J. S., Yu, J. M., Yu, S. S., Choi, S. J., Kim, D. H., & Jung, J. S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.029 · Cited by 43
RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities
Srivastava, A., Rikhari, D., & Srivastava, S. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.013 · Cited by 42 · cited 1×
“RSPO mutations, gene rearrangements, fusions, copy number alterations, and altered gene expression have also been identified in a variety of cancers including CRC [203].”
BackgroundPrabhu, V. V., Lulla, A. R., Madhukar, N. S., Ralff, M. D., Zhao, D., Kline, C. L. B., van den Heuvel, A. P. J., Lev, A., Garnett, M. J., McDermott, U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180541 · Cited by 42 · cited 1×
“Furthermore, research has demonstrated that ONC201 significantly inhibits the expression of CSC-related genes in prostate tumors and GBMs by suppressing the Wnt/β-catenin pathway [342].”
BackgroundKim, Y.-H., Hong, S., Noh, M. R., Kim, S., Huh, P., Park, S., Sun, W., & Kim, H. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)17384-5 · Cited by 42
Ji, L., Lu, B., Wang, Z., Yang, Z., Reece-Hoyes, J. S., Russ, C., Xu, W., & Cong, F. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.040 · Cited by 41 · cited 1×
“Furthermore, ICAT acts as a natural inhibitor of APC, thereby preventing APC-mediated degradation of β-catenin and exerting a positive effect on Wnt signaling [79].”
BackgroundChen, Y., Rao, X., Huang, K., Jiang, X., Wang, H., & Teng, L. (2017) · Journal of Cancer · doi:10.7150/jca.19273 · Cited by 41 · cited 1×
“Similarly, FH535 exhibits comparable effects by repressing the expression of liver CSC markers CD24 and CD44 [346].”
BackgroundAlterations of the WNT7A Gene in Clear Cell Renal Cell Carcinomas
Kondratov, O., Kvasha, S. M., Stoliar, L. A., Am, R., Zgonnyk, Y. M., Gordiyuk, V. V., Kashuba, E., Rynditch, A. V., Zabarovsky, E. R., & Kashuba, V. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047012 · Cited by 41 · cited 1×
“Some of these aberrations include upregulation of Wnt1 [249] and Wnt10a [250], as well as downregulation of Wnt5a [251] and Wnt7a [252].”
BackgroundChen, D., Sg, L., Chen, J.-Y., & Xiao, M. (2018) · PubMed · doi:10.26355/eurrev_201808_15618 · Cited by 41 · cited 1×
“In breast cancer, miR-183 has been identified as a direct inhibitor of key components of the DC, including AXIN1, AXIN2, and GSK3β, to activate the canonical Wnt signaling [139, 140].”
BackgroundBmi1 is required for tumorigenesis in a mouse model of intestinal cancer
Maynard, M. A., Ferretti, R., Hilgendorf, K. I., Perret, C., Whyte, P., & Lees, J. A. (2013) · Oncogene · doi:10.1038/onc.2013.333 · Cited by 40 · cited 1×
“The ablation of cells expressing Bmi1 or directly elimination of Lgr5-positive cells has demonstrated a reduction in intestinal tumor burden [208, 209].”
BackgroundWang, H., Yan, B., Zhang, P., Liu, S., Li, Q., Yang, J., Yang, F., & Chen, E. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29066 · Cited by 38 · cited 1×
“In CRC, RAS association domain family 6 (RASSF6) is evidenced to be inhibited by miR-496, resulting in the Wnt/β -catenin signaling activation along with enhanced migration and EMT of CRC [151].”
BackgroundAberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival
Lu, Y. W., GUAN, G.-F., Chen, J., Hu, B., Sun, C., Ma, Q., Wen, Y., Qiu, X., & Zhou, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3535 · Cited by 38 · cited 1×
“It has been observed that OS tissues exhibit elevated levels of β-catenin compared to adjacent healthy tissues, resulting in poor prognosis and the occurrence of lung metastasis [270].”
BackgroundWNT5A Is Regulated by PAX2 and May Be Involved in Blastemal Predominant Wilms Tumorigenesis
Tamimi, Y., Ekuere, U., Laughton, N., & Grundy, P. E. (2008) · Neoplasia · doi:10.1593/neo.08442 · Cited by 38 · cited 1×
“Some of these aberrations include upregulation of Wnt1 [249] and Wnt10a [250], as well as downregulation of Wnt5a [251] and Wnt7a [252].”
BackgroundMethylation ofDickkopf-3as a prognostic factor in cirrhosis-related hepatocellular carcinoma
Yang, B. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i6.755 · Cited by 38
Yoshikawa, H., Matsubara, K., Zhou, X., Okamura, S., Kubo, T., Murase, Y., Shikauchi, Y., Esteller, M., Herman, J. G., Wei Wang, X., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-10-0889 · Cited by 37
LRP5/6 in Wnt Signaling and Tumorigenesis
Li, Y., & Bu, G. (2005) · Future Oncology · doi:10.2217/14796694.1.5.673 · Cited by 36 · cited 1×
“LRP5/6 are low-density lipoprotein receptor-related proteins on the plasma membrane, functioning as coreceptors for Wnts [35].”
BackgroundPhillips, C., Bhamra, I., Eagle, C., Flanagan, E., Armer, R., Jones, C. D., Bingham, M., Calcraft, P., Edmenson Cook, A., Thompson, B., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0095 · Cited by 36
Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma
Guo, C., Zhang, X., Yang, B., Geng, J., Peng, B., & Zheng, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2077 · Cited by 36 · cited 2×
“Guo et al. discovered a significant decrease in serum levels of DKK1 and DKK3 among ccRCC patients compared to healthy individuals [258].”
BackgroundThe canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma
Zhao, J. (2013) · Frontiers in bioscience · doi:10.2741/4187 · Cited by 36 · cited 1×
“The activity of the Wnt pathway is closely tied to bone development and growth, and its dysregulation can lead to corresponding pathological conditions [275].”
BackgroundKang, Y., Zhang, S., Cao, W., Wan, D., & Sun, L. (2020) · Bioscience Reports · doi:10.1042/bsr20193450 · Cited by 36 · cited 1×
“It is capable of promoting EMT of HCC cells through the upregulation of Wnt2, FZD4 and β-catenin expression [152–154].”
BackgroundWon, H. S., Lee, K. M., Oh, J. E., Nam, E. M., & Lee, K. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155983 · Cited by 35
Regulator of G Protein Signaling 3 Modulates Wnt5b Calcium Dynamics and Somite Patterning
Freisinger, C. M., Fisher, R. A., & Slusarski, D. C. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001020 · Cited by 35 · cited 1×
“Their crucial role in development has been established by extensive research [15, 16], although further investigations are warranted.”
BackgroundTrujano-Camacho, S., León, D. F. C.-D., Delgado-Waldo, I., Coronel-Hernández, J., Millán-Catalán, O., Hernández‐Sotelo, D., López‐Camarillo, C., Pérez‐Plasencia, C., & Campos-Parra, A. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.729228 · Cited by 34
Rodriguez-Blanco, J., Li, B., Long, J., Shen, C., Yang, F., Orton, D., Collins, S., Kasahara, N., Ayad, N. G., McCrea, H. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1319 · Cited by 34 · cited 1×
“SSTC3, a small molecule activator of CK1α, can inhibit the growth of heterologous transplants in CRC [321, 322].”
BackgroundEIF3E–RSPO2 and PIEZO1–RSPO2 fusions in colorectal traditional serrated adenoma
Hashimoto, T., Ogawa, R., Yoshida, H., Taniguchi, H., Kojima, M., Saito, Y., & Sekine, S. (2019) · Histopathology · doi:10.1111/his.13867 · Cited by 34 · cited 1×
“EIF3E-RSPO2 fusion was identified in CRC and PIEZ01-RSPO2 was also identified in cDNA ends [204].”
BackgroundUrushibara, S., Tsubota, T., Asai, R., Azumi, J., Ashida, K., Fujiwara, Y., & Shiota, G. (2017) · Anticancer Research · doi:10.21873/anticanres.11795 · Cited by 34
The APC Tumor Suppressor Promotes Transcription-Independent Apoptosis In vitro
Steigerwald, K., Behbehani, G. K., Combs, K. A., Barton, M. C., & Groden, J. L. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-03-0189 · Cited by 33
Wang, W., He, Y., Rui, J., & Xu, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.9710 · Cited by 33 · cited 1×
“Evidence demonstrated that miR-410 possesses the ability to effectively inhibit DKK1 and DKK3, thereby facilitating the translocation of β-catenin into the nucleus [147].”
BackgroundLiu, T., Li, Z., & Tian, F. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211030558 · Cited by 32 · cited 1×
“The interaction between SIRT6 and FZD4 leads to the suppression of FZD4 transcription by reducing histone H3K9 acetylation in HCC [121].”
BackgroundSweeney, K., Cameron, E. R., & Blyth, K. (2020) · PubMed Central · doi:10.14348/molcells.2019.0310 · Cited by 32 · cited 1×
“The relationship between the RUNX family and Wnts is intricate, as the RUNXs are able to regulate the expression of Wnt, while the β-catenin is able to mediate the expression of RUNX [76].”
BackgroundCui, J., Li, P., Liu, X., Hu, H., & Wei, W. (2015) · Oncology Letters · doi:10.3892/ol.2015.2942 · Cited by 31 · cited 2×
“This suggests a close association between β-catenin and the self-renewal function of breast CSCs [232].”
BackgroundLoss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response
Neumeyer, V., Brutau-Abia, A., Allgäuer, M., Pfarr, N., Weichert, W., Falkeis-Veits, C., Kremmer, E., Vieth, M., Gerhard, M., & Mejías-Luque, R. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.11.005 · Cited by 30 · cited 1×
“The absence of RNF43 can enhance resistance to γ-radiation and chemotherapy of gastrointestinal cancers cells by inhibiting the activation of DNA damage response [96].”
BackgroundYang, Y., Xing, Y., Liang, C., Hu, L., Xu, F., & Chen, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3227-3 · Cited by 30
Cui, Y., Ma, W., Lei, F., Li, Q., Su, Y., Lin, X., Lin, C., Zhang, X., Ye, L., Wu, S., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4725 · Cited by 30
R-spondin family biology and emerging linkages to cancer
He, Z., Zhang, J., Ma, J., Zhao, L., Jin, X., & Li, H. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2166981 · Cited by 29 · cited 1×
“R-spondins, consisting of four members (RSPO1-4), function as enhancers in the Wnt/β-catenin signaling pathway and are considered indispensable factors in carcinogenesis [58].”
BackgroundLu, Q., Huang, H., Wang, X., Luo, L., Xia, H., Zhang, L., Xu, J., Huang, Y., Luo, X., & Luo, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106760 · Cited by 29 · cited 1×
“Furthermore, a study has demonstrated that Echinatin (Ecn), a naturally occurring active compound, exerts inhibitory effects on the proliferation, migration, and invasion of OS cells by suppressing the Wnt/β-catenin signaling pathway while simultaneously activating the p38 signaling pathway [273].”
BackgroundSelf-citationGoldsberry, W. N., Meza‐Perez, S., Londoño, A. I., Katre, A. A., Mott, B. T., Roane, B. M., Goel, N., Wall, J., Cooper, S. J., Norian, L. A., et al. (2020) · Cancers · doi:10.3390/cancers12030766 · Cited by 29 · cited 1×
“CGX1321, another PORCN inhibitor, has been demonstrated to reduce tumor cell burden, enhance immune cell infiltration, and improve survival rate in an EOC mouse model [283].”
BackgroundLipid modification in Wnt structure and function
Ke, J., Xu, H. E., & Williams, B. O. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835df2bf · Cited by 28 · cited 2×
“Wnt proteins play a pivotal role in executing diverse biological functions [21].”
BackgroundCharawi, S., Just, P., Savall, M., Abitbol, S., Traoré, M., Metzger, N., Ravinger, R., Cavard, C., Terris, B., & Perret, C. (2018) · The Journal of Pathology · doi:10.1002/path.5202 · Cited by 27
Zhan, N., Michael, A. A., Wu, K., Zeng, G., Bell, A. W., Tao, J., & Monga, S. P. (2018) · Gene Expression · doi:10.3727/105221618x15174108894682 · Cited by 27 · cited 1×
“The activation of Wnt/β-catenin alone is insufficient to drive hepatocarcinogenesis; instead, its interactions with c-Met, K-RasV12, activated Akt, LKB1, and Nrf2 are necessary for HCC formation in mice. c-Met c-Met has been observed in 10% of human HCC tissue samples [220–224].”
BackgroundMeng (2010) · Oncology Reports · doi:10.3892/or_00000960 · Cited by 27
A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells
瀬戸健造, Sakabe, T., Itaba, N., Azumi, J., Oka, H., Morimoto, M., Umekita, Y., & Shiota, G. (2017) · Anticancer Research · doi:10.21873/anticanres.11727 · Cited by 27 · cited 1×
“IC-2, a small molecule inhibitor, effectively diminishes the population of CD44 cells (liver CSCs) and impedes sphere-forming capacity in HCC, CRC, and bladder cancer cells [343–345].”
BackgroundMetformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
Kang, H. E., Seo, Y., Yun, J. S., Song, S. H., Han, D., Cho, E. S., Cho, S. B., Jeon, Y., Lee, H., Kim, H. S., et al. (2021) · Cancers · doi:10.3390/cancers13143437 · Cited by 27 · cited 1×
“Niclosamide, an anti-helminthic compound, has demonstrated efficacy in promoting FZD endocytosis while downregulating DVL-2 and inhibiting β-catenin [297, 298].”
BackgroundXin, Y., Jin, Y., Ge, J., Huang, Z., Han, L., Li, C., Wang, D., Zhu, S., & Wang, Q. (2020) · Cell Proliferation · doi:10.1111/cpr.12940 · Cited by 25 · cited 2×
“Studies have demonstrated that the members of sirtuin (SIRT) family of deacety-lases including SIRT1, SIRT2, and SIRT3 can mediate deacetylation to inhibit GSK3β activity [114, 115].”
BackgroundTargeting LRP6: A new strategy for cancer therapy
Xue, W., Zhu, B., Zhao, K., Huang, Q., Luo, H., Shou, Y., Huang, Z., & Guo, H. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107200 · Cited by 24 · cited 1×
“Niclosamide, calcipotriol, Salinomycin, pantoprazole and monensin downregulates the total and p-LRP6, leading to its degradation and inhibition of Wnt/ β-catenin signaling pathway [294, 295].”
BackgroundNHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway–Driven Intestinal Neoplasia
Georgescu, M., Gagea, M., & Cote, G. J. (2016) · Neoplasia · doi:10.1016/j.neo.2016.07.003 · Cited by 24 · cited 1×
“Na + /H + exchanger regulatory factor 1, an adaptor molecule known to suppress Wnt signaling has been identified to be downregulated in CRC cells due to the DNMT1-mediated promotor methylation [135].”
BackgroundSchlensog, M., Magnus, L., Heide, T., Eschenbruch, J., Steib, F., Tator, M., Kloten, V., Rose, M., Noetzel, E., Gaisa, N. T., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1229730 · Cited by 24
Yang, Q., Qin, T., An, T., Wu, H., Xu, G., Xiang, J., Lei, K., Zhang, S., Xia, J. L., Su, G., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175628 · Cited by 22 · cited 1×
“WHN-88, a recently developed PORCN inhibitor, effectively impedes the palmitoylation of Wnt ligands, thereby obstructing their secretion as well as the Wnt/β-catenin signaling pathway activation [284].”
BackgroundElfert, S., Weise, A., Bruser, K., Biniossek, M. L., Jägle, S., Senghaas, N., & Hecht, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061867 · Cited by 21 · cited 1×
“TCF4 undergoes acetylation at K150 in conjunction with CBP, leading to conformational changes in the TCF4-DNA complex [132].”
BackgroundDiagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis
Hu, H., Li, B., Zhou, C., Ying, X., Chen, M., Huang, T., Chen, Y., Ji, H., Pan, R., Wang, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23870 · Cited by 20
Discovery of a small-molecule inhibitor of Dvl–CXXC5 interaction by computational approaches
Ma, S., Choi, J., Jin, X., Kim, H.-Y., Yun, J.-H., Lee, W., Choi, K., & No, K. T. (2018) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-018-0118-x · Cited by 19 · cited 1×
“NSC668036, FJ9, and 3289–8625 effectively block the interaction between DVL PDZ domain and FZD, subsequently inhibiting signal transduction pathways [299–302].”
BackgroundIn silico discovery of quinoxaline derivatives as novel LRP5/6-sclerostin interaction inhibitors
Choi, J., Lee, K., Kang, M., Lim, S.-K., & No, K. T. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.050 · Cited by 17 · cited 1×
“Through competitive binding to the LRP5/6-sclerostin complex, BMD4503-2 has the potential to restore the decreased activity of the Wnt/β-catenin signaling pathway [292].”
Backgroundβ-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients
Schirosi, L., Mazzotta, A., Opinto, G., Pinto, R., Graziano, G., Tommasi, S., Fucci, L., Simone, G., & Mangia, A. (2016) · Oncotarget · doi:10.18632/oncotarget.12280 · Cited by 17
Warner, D. R., Smith, S. C., Smolenkova, I. A., Pisano, M., & Greene, R. M. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.02.015 · Cited by 16 · cited 1×
“By inhibiting CBP’s HAT function, C646 blocks the acetylation of histones, leading to the repression of Wnt target gene transcription [338].”
BackgroundValkenburg, K. C., Hostetter, G. H., & Williams, B. O. (2015) · The Prostate · doi:10.1002/pros.23032 · Cited by 16 · cited 1×
“Moreover, APC deletion in combination with the prostate oncogene Hepsin overexpression facilitates prostate cancer progression [238].”
BackgroundDown‐regulation of dishevelled‐2 inhibits cell proliferation and invasion in hepatoblastoma
Huang, S., Chen, J., Tian, R., Wang, J., Xie, C., Gao, H., Shan, Y., Hong, J., Zhang, Z., Xu, M., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27032 · Cited by 15 · cited 1×
“Niclosamide, an anti-helminthic compound, has demonstrated efficacy in promoting FZD endocytosis while downregulating DVL-2 and inhibiting β-catenin [297, 298].”
BackgroundHartman, M. L., Talar, B., Gajos-Michniewicz, A., & Czyż, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128796 · Cited by 15 · cited 1×
“In terms of melanocyte development, the Wnt signaling pathway assumes a pivotal role by activating the microphthalmia-associated transcription factor, which regulates cell survival, proliferation, and differentiation processes [241].”
BackgroundKim, J. W., Yang, J. H., & Kim, E. (2020) · Animal Cells and Systems · doi:10.1080/19768354.2020.1726461 · Cited by 14 · cited 2×
“Studies have demonstrated that the members of sirtuin (SIRT) family of deacety-lases including SIRT1, SIRT2, and SIRT3 can mediate deacetylation to inhibit GSK3β activity [114, 115].”
BackgroundNing, M., Cheng, Z.-L., & Zhao, J. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa024 · Cited by 14
Song, H., Nan, Y.-H., Wang, X., Zhang, G., Zong, S., & Kong, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7076 · Cited by 13 · cited 1×
“The elevated protein expression level of FZD7 and restoration of FZD7 function effectively reverses the inhibitory effect exerted by the tumor suppressor miR-613 on RCC cell proliferation and invasion [254].”
BackgroundSchaeffer, S., Gupta, B., Calatayud, A.-L., Caldéraro, J., Caruso, S., Hirsch, T. Z., Pelletier, L., Zucman‐Rossi, J., & Rebouissou, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.004 · Cited by 12 · cited 1×
“RSK2-inactivating mutations frequently co-occur with AXIN1-inactivating or β-catenin-activating mutations, which play a synergistic role in promoting HCC development [92].”
BackgroundPyrvinium doubles against WNT-driven cancer
Fan, J., Reid, R. R., & He, T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102479 · Cited by 11 · cited 1×
“Moreover, pyrvinium directly activates CK1α kinase activity by attenuating CRBN-mediated degradation of CK1α, further suppressing canonical Wnt signal transduction [320].”
BackgroundPaschidis, K., Zougros, A., Chatziandreou, I., Tsikalakis, S., Korkolopoulou, P. A., Kavantzas, N., & Saetta, A. A. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153899 · Cited by 11 · cited 1×
“In lung carcinoma, APC promoter methylation has been correlated with smoking status and non-metastatic cases [122], while methylation in APC has been observed to be associated with an increased risk of prostate cancer-specific mortality [123].”
BackgroundOverexpression of TWA1 predicts poor prognosis in patients with gastric cancer
Xiong, J., Feng, Z., Li, Z., Zhong, T., Yang, Z., Tu, Y., Xiao, T., Jie, Z., & Cao, Y. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152594 · Cited by 11 · cited 1×
“Twa, a two hybrid-associated protein no.1 with RanBPM, also known as glucose-induced degradation protein 8 homolog, has been identified in colorectal carcinoma tissues [77].”
BackgroundRegulation of Wnt distribution and function by Drosophila glypicans
Waghmare, I., & Page, A. W. (2022) · Journal of Cell Science · doi:10.1242/jcs.259405 · Cited by 11 · cited 1×
“GPCs, a class of evolutionarily conserved heparan sulfate proteoglycans, have been demonstrated to localize on the plasma membrane and exhibit the ability to bind to Wnt proteins for the regulation of their extracellular distribution and signaling activity [52].”
BackgroundRen, Z.-F., Du, M.-F., Fu, H., Liu, J., Xia, F.-Y., Du, H.-N., & Liu, N. (2020) · PubMed · doi:10.26355/eurrev_202005_21336 · Cited by 10
Contribution of CRNDE lncRNA in the development of cancer and the underlying mechanisms
Ghafouri‐Fard, S., Safarzadeh, A., Hussen, B. M., Taheri, M. N., & Mokhtari, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154387 · Cited by 9 · cited 1×
“It is capable of promoting EMT of HCC cells through the upregulation of Wnt2, FZD4 and β-catenin expression [152–154].”
BackgroundYuan-Hada, H. E., Su, R., & Zheng, J. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-05982-3 · Cited by 9 · cited 1×
“It has been proven to be related to poor prognosis [106–108].”
BackgroundChoi, R. B., Hoggatt, A. M., Horan, D. J., Rogers, E. Z., Hong, J. M., & Robling, A. G. (2022) · Aging and Disease · doi:10.14336/ad.2022.0315 · Cited by 8 · cited 1×
“These findings suggest that DKK plays a crucial role in negatively regulating bone mass in aging individuals [353].”
BackgroundZhang, B., Ji, J., Hu, M., Zhou, X., Nie, Q., Xu, H., Jiang, C., Fu, Y., & Li, L. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13743 · Cited by 8
Yang, X., XIANG, X., XU, G., ZHOU, S., An, T., & Huang, Z. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.030768 · Cited by 8 · cited 1×
“Evidence suggests that silencing PRDX2 results in the induction of senescence in HCC cells [226].”
BackgroundPrognostic Significance of CTNNB1 Mutation in Recurrence of Sporadic Desmoid Tumors
Guo, L., Wang, X., Xu, B., Lang, R., & Hu, B. (2021) · Future Oncology · doi:10.2217/fon-2020-0544 · Cited by 7 · cited 1×
“A meta-analysis identified that with CTNNB1 S45F mutation, the desmoid tumor is more likely to reoccur [100].”
BackgroundLncRNA UCA1 accelerates osteosarcoma progression via miR-145 and Wnt/β-catenin pathway.
Guan, J., He, J., Liao, S., Wu, Z., Lin, X., Liu, B., Xiong, Q., Tan, J., Huang, C., Yuan, Z., et al. (2022) · PubMed · Cited by 5
Research works printed but not linked: 6
- Nusse R Clevers H Wnt/beta-Catenin signaling, Disease, and emerging therapeutic modalities Cell 2017 169 6 985 99 10.1016/j.cell.2017.05.016 28575679 · DOI · Paper page
- Cai J Fang L Huang Y Li R Xu X Hu Z Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by mir-128-3p confers chemoresistance-associated metastasis in NSCLC Nat Commun 2017 8 15870 10.1038/ncomms15870 28627514 PMC5481840 · DOI · Paper page
- Chai S Ng KY Tong M Lau EY Lee TK Chan KW Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells Hepatology 2016 64 6 2062 76 10.1002/hep.28821 27639189 · DOI · Paper page
- Wang Z Li Z Ji H Direct targeting of β-catenin in the wnt signaling pathway: current progress and perspectives Med Res Rev 2021 41 4 2109 29 10.1002/med.21787 33475177 PMC8217106 · DOI
- Jung YS Park JI Wnt signaling in cancer: therapeutic targeting of wnt signaling beyond β-catenin and the destruction complex Exp Mol Med 2020 52 2 183 91 10.1038/s12276-020-0380-6 32037398 PMC7062731 · DOI · Paper page
- Zhao H Ming T Tang S Ren S Yang H Liu M Wnt signaling in colorectal cancer: pathogenic role and therapeutic target Mol Cancer 2022 21 1 144 10.1186/s12943-022-01616-7 35836256 PMC9281132 · DOI · Paper page
Cited by
Helicobacter pylori and gastric cancer: mechanisms and new perspectives
Duan, Y., Xu, Y., Dou, Y., & Xu, D. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01654-2 · Cited by 300
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., Kang, W., Lee, J.-M., Youn, H., & Youn, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02360-2 · Cited by 188
Yu, B., & Ma, W. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.08.006 · Cited by 121
Cell migration in diabetic wound healing: Molecular mechanisms and therapeutic strategies (Review)
Song, J., Zhao, T., Wang, C., Sun, X., Sun, J., & Zhang, Z. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5567 · Cited by 116
“7) (146).”
Galasso, L., Termite, F., Mignini, I., Esposto, G., Borriello, R., Vitale, F., Nicoletti, A., Paratore, M., Ainora, M. E., Gasbarrini, A., et al. (2025) · Cancers · doi:10.3390/cancers17030368 · Cited by 90
“Activation of this pathway by F. nucleatum has been associated with poor outcomes in CRC patients due to its role in driving uncontrolled tumor growth and metastasis [23,24].”
Metadata
- Authors
- Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X.
- Affiliations
- West China Hospital of Sichuan University (CN)
- Sichuan University (CN)
- Corresponding author
- Dong, Qiang
- Wei, Xiawei
- Venue
- Journal of Hematology & Oncology
- Published
- 2024-06-18
- Volume
- 17
- Issue
- 1
- Pages
- 46-46
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC11184729
- OpenAlex
- W4399792819
- Cited by
- 382
- References
- 354
- Citations by year
- 2026: 167 · 2025: 193 · 2024: 22
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Foundation for Excellent Young Scholars (32122052)
- National Natural Science Foundation Regional Innovation and Development (No. U19A2003)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt/β-catenin signaling, carcinogenesis, cancer therapy, targeted therapy, tumor initiation and progression, epigenetic modifications, signaling crosstalk, Wnt inhibitors, cell proliferation, tissue homeostasis
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, beta Catenin, Molecular Targeted Therapy, Wnt Signaling Pathway, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.